title: High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.
authors.affiliation: Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
authors.forename: Mohsen
authors.initials: M
authors.lastname: Karimi
authors.affiliation: Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
authors.forename: Christer
authors.initials: C
authors.lastname: Nilsson
authors.affiliation: Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
authors.forename: Marios
authors.initials: M
authors.lastname: Dimitriou
authors.affiliation: Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
authors.forename: Monika
authors.initials: M
authors.lastname: Jansson
authors.affiliation: Department of Biosciences and Nutrition and Center for Innovative (CIMED), Karolinska Institutet, Sweden.
authors.forename: Hans
authors.initials: H
authors.lastname: Matsson
authors.affiliation: Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm, Sweden.
authors.forename: Per
authors.initials: P
authors.lastname: Unneberg
authors.affiliation: Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
authors.forename: Sören
authors.initials: S
authors.lastname: Lehmann
authors.affiliation: Department of Biosciences and Nutrition and Center for Innovative (CIMED), Karolinska Institutet, Sweden Molecular Neurology Research Program, University of Helsinki and Folkhälsan Institute of Genetics, Helsinki, Finland.
authors.forename: Juha
authors.initials: J
authors.lastname: Kere
authors.affiliation: Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden Eva.Hellstrom-Lindberg@ki.se.
authors.forename: Eva
authors.initials: E
authors.lastname: Hellström-Lindberg
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002478:Cells, Cultured; D015331:Cohort Studies; D005260:Female; D005820:Genetic Testing / Q000379:methods*; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000235:genetics*; D012042:Registries; D015996:Survival Rate / Q000639:trends
keywords: acute myeloid leukemia; high-throughput mutational screening; myelodysplastic syndromes; secondary; therapy-related